PMC:7144273 / 811-1054 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T20","span":{"begin":118,"end":126},"obj":"SP_7"},{"id":"T94035","span":{"begin":118,"end":126},"obj":"SP_7"}],"text":"atory infection.\nThere is a rapidly increasing number of clinical investigations of cell-based therapy approaches for COVID-19. These utilise a range of different cell sources, doses, dosing strategies and targeted patient populations. To prov"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":84,"end":88},"obj":"Body_part"},{"id":"T7","span":{"begin":163,"end":167},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"atory infection.\nThere is a rapidly increasing number of clinical investigations of cell-based therapy approaches for COVID-19. These utilise a range of different cell sources, doses, dosing strategies and targeted patient populations. To prov"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T13","span":{"begin":6,"end":15},"obj":"Disease"},{"id":"T14","span":{"begin":118,"end":126},"obj":"Disease"}],"attributes":[{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"atory infection.\nThere is a rapidly increasing number of clinical investigations of cell-based therapy approaches for COVID-19. These utilise a range of different cell sources, doses, dosing strategies and targeted patient populations. To prov"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T11","span":{"begin":26,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T12","span":{"begin":84,"end":88},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T13","span":{"begin":142,"end":143},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T14","span":{"begin":163,"end":167},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"atory infection.\nThere is a rapidly increasing number of clinical investigations of cell-based therapy approaches for COVID-19. These utilise a range of different cell sources, doses, dosing strategies and targeted patient populations. To prov"}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":17,"end":127},"obj":"Sentence"},{"id":"T8","span":{"begin":128,"end":235},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"atory infection.\nThere is a rapidly increasing number of clinical investigations of cell-based therapy approaches for COVID-19. These utilise a range of different cell sources, doses, dosing strategies and targeted patient populations. To prov"}

{"project":"LitCovid-PubTator","denotations":[{"id":"37","span":{"begin":215,"end":222},"obj":"Species"},{"id":"38","span":{"begin":57,"end":65},"obj":"Species"},{"id":"42","span":{"begin":118,"end":126},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"Tax:9606"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"Tax:191496"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"atory infection.\nThere is a rapidly increasing number of clinical investigations of cell-based therapy approaches for COVID-19. These utilise a range of different cell sources, doses, dosing strategies and targeted patient populations. To prov"}